| 恩替卡韦治疗慢性乙型重症肝炎的临床研究 |
| |
| 引用本文： | 徐春华. 恩替卡韦治疗慢性乙型重症肝炎的临床研究[J]. 现代预防医学, 2010, 37(9) |
| |
| 作者姓名： | 徐春华 |
| |
| 作者单位： | 湖南省长沙市第一医院,长沙,410011 |
| |
| 摘 要： | [目的]探讨恩替卡韦治疗慢性乙型重症肝炎的临床疗效。[方法]选择2008年10月～2009年12月期间某院收治的慢性乙型重症肝炎患者52例,随机将患者分为治疗组27例和对照组25例。对照组采用一般护肝治疗,而治疗组在此基础上给予恩替卡韦。[结果]与对照组相比,恩替卡韦治疗组可以明显的降低治疗后TB的含量,并能显著提高总有效率,降低无效率以及显著降低HBV-DNA含量,差异均具有统计学意义(P﹤0.05)。[讨论]恩替卡韦是治疗慢性乙型重症肝炎的有效药物,在临床上值得广泛应用。
|
| 关 键 词： | 恩替卡韦 慢性乙型重症肝炎 抗病毒治疗 |
CLINICAL RESEARCH ON TREATMENT FOR CHRONIC SEVERE HEPATITIS B WITH ENTECAVIR |
| |
| XU Chun-hua. CLINICAL RESEARCH ON TREATMENT FOR CHRONIC SEVERE HEPATITIS B WITH ENTECAVIR[J]. Modern Preventive Medicine, 2010, 37(9) |
| |
| Authors: | XU Chun-hua |
| |
| Affiliation: | XU Chun-hua. (First Hospital of Changsha City in Hunan Province,Changsha 410011,China) |
| |
| Abstract: | [Objective] To probe of clinical research on treatment for chronic severe hepatitis B with Entecavir. [Methods] Selected 52 cases with severe chronic hepatitis B admitted to our hospital during October 2008-December 2009, patients were randomly divided into treatment group (27 cases) and control group (25 cases). Liver treatment was commonly used in the control group, besides the common treatment, the treatment group was given Entecavir. [Results] Compared with the control group, Entecavir treatment group s... |
| |
| Keywords: | Entecavir Chronic severe hepatitis B Antiviral therapy |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
